Combination immunotherapy with IL-2 surface-modified tumor cell vaccine and PD-1 blockade against renal cell carcinoma
Studies show that immunotherapy may be an effective way to prevent postoperative recurrence of renal cell carcinoma.10/29/2018
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Carcinoma | Immunotherapy | Kidney Cancer | Renal Cell Carcinoma | Study | Urology & Nephrology | Vaccines